Literature DB >> 17613976

Epidemiology of opium use in the general population.

Jamshid Ahmadi1, Saxby Pridmore, Abbas Alimi, Ahmad Cheraghi, Ahmad Arad, Hamid Parsaeyan, Mohammad Sadegh Mohagheghzadeh, Mohsen Kianpour.   

Abstract

AIMS: To evaluate the prevalence of opium use in the Fars province, Iran.
METHOD: A household survey of a representative sample of 3840 people aged 15 years and over. Researchers assessed opium use disorders using a semistructured interview and the Research Version of the Structured Clinical Interview for DSM-IV Axis I, during 2003.
RESULTS: Mean age of the sample was 33.9 years (SD = 15). Of the participants, 689 (17.9%) admitted use of opium one or more times during their lives (28.4% of men and 7.4% of women). Three hundred thirty-nine (8.8%) were current opium users (14.3% of men and 3.3% of women). Opium ever-use and current-use were not functions of marital status. Both opium ever-use and current-use are found across the educational, occupational and income spectrums. Both peaked in the 40-49 age category, suggesting that first use usually occurs before 40 years of age and that current use extends across all age groups.
CONCLUSION: Men are at greater risk than women. This report provides useful information for health planning. Prevention programs should focus on those under 40 years of age, and treatment is required across all age groups.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613976     DOI: 10.1080/00952990701301293

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  16 in total

1.  Socio-demographic characteristics of the addicted inmates of Qom and Tabriz prisons in Iran.

Authors:  Mohammadreza Sattari; Mina Islambulchilar; Mohsen Toluyi; Siminozar Mashayekhi
Journal:  Adv Pharm Bull       Date:  2012-03-15

2.  Relationship between Opium Abuse and Severity of Depression in Type 2 Diabetic Patients.

Authors:  Sepehrmanesh Zahra; Sarmast Hossein; Kord Valeshabad Ali
Journal:  Diabetes Metab J       Date:  2012-04-17       Impact factor: 5.376

3.  Opium Addiction and Correlation with Early and Six-month Outcomes of Presenting with ST Elevation Myocardial Infarction Treated Initially with Thrombolytic Therapy.

Authors:  Mehdi Mousavi; Solmaz Kalhor; Mahlaa Alizadeh; Mohamad Reza Movahed
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

4.  The Association of Opium Abuse with Mortality Amongst Hospitalized COVID-19 Patients in Iranian Population.

Authors:  Alireza Mirahmadizadeh; Alireza Heiran; Amineh Dadvar; Mohammad Javad Moradian; Mohammad Hossein Sharifi; Roya Sahebi
Journal:  J Prev (2022)       Date:  2022-06-02

5.  Study of sociodemographic correlates, anxiety, and depression among opioid dependents admitted in treatment centres in Sikkim, India.

Authors:  Bishnu Sharma; Samrat Singh Bhandari; Sanjiba Dutta; Geeta Soohinda
Journal:  Open J Psychiatry Allied Sci       Date:  2019-02-25

6.  Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran.

Authors:  Hajar Shekarchizadeh; Hamed Ekhtiari; Mohammad R Khami; Jorma I Virtanen
Journal:  Harm Reduct J       Date:  2012-06-07

7.  Opium addiction and severity of coronary artery disease: a case-control study.

Authors:  Mohammad Masoumi; Armita Shahesmaeili; Ali Mirzazadeh; Marjan Tavakoli; Arghavan Zia Ali
Journal:  J Res Med Sci       Date:  2010-01       Impact factor: 1.852

8.  Is opium addiction a risk factor for bone loss?

Authors:  M H Gozashti; A Shahesmaeili; N Amini Zadeh
Journal:  Iran Red Crescent Med J       Date:  2011-07-01       Impact factor: 0.611

9.  The effect of opium addiction on thyroid function tests.

Authors:  Mohammad Hossein Gozashti; Elham Mohammadzadeh; Kouros Divsalar; Mostafa Shokoohi
Journal:  J Diabetes Metab Disord       Date:  2014-01-06

10.  A prospective cohort study of cutaneous leishmaniasis risk and opium addiction in south eastern Iran.

Authors:  Mohammad Reza Aflatoonian; Iraj Sharifi; Maryam Hakimi Parizi; Ali Reza Fekri; Behnaz Aflatoonian; Maryam Sharifi; Ahmad Khosravi; Ali Khamesipour; Hamid Sharifi
Journal:  PLoS One       Date:  2014-02-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.